Last update 11 Sep 2025

BA-1106

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
BA 1106, BA-1106, RR-102
+ [1]
Target
IL2RA
Action
inhibitors
Mechanism
IL2RA inhibitors(Interleukin-2 receptor alpha chain inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmSolid tumor
Inactive Indication-
Originator Organization
Shandong Boan Biotechnology Co., Ltd.Shandong Boan Biotechnology Co., Ltd.
Active Organization
Shandong Boan Biotechnology Co., Ltd.Shandong Boan Biotechnology Co., Ltd.Luye Pharma AGLuye Pharma AG
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with BA-1106
NCT05650242
/ RecruitingPhase 1
An Non-randomized Open-label, Multicenter Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, Preliminary Efficacy of BA1106 in Participants With Advanced Solid Tumors
100 Clinical Results associated with BA-1106
Login to view more data
100 Translational Medicine associated with BA-1106
Login to view more data
100 Patents (Medical) associated with BA-1106
Login to view more data
100 Deals associated with BA-1106
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
Shandong Boan Biotechnology Co., Ltd.Shandong Boan Biotechnology Co., Ltd.
31 Jan 2023
Solid tumorPhase 1
China
Luye Pharma AGLuye Pharma AG
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
AACR2025
Not Applicable
Advanced Malignant Solid Neoplasm
-
ixmoxjspyh(nagllqruvm) = Out of 26 patients with at least one efficacy assessment, 9 achieved stable disease (SD), with a disease control rate (DCR) of 34.6% jnqqirlrtv (cqrfqcrgxw )
View more
-
28 Apr 2025
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free